Related Experiment Video
Updated: Jan 24, 2026

Visualizing Dengue Virus through Alexa Fluor Labeling
Published on: July 9, 2011
Recent update on anti-dengue drug discovery
Satish N Dighe1, O'mezie Ekwudu1, Kamal Dua2
1Innovative Medicines Group, Institute of Health & Biomedical Innovation, School of Clinical Sciences, Queensland University of Technology, Brisbane, Australia.
New small molecules show promise for dengue virus (DENV) treatment. This review covers recent advances in DENV drug discovery and targets, offering hope for effective therapies against this widespread mosquito-borne illness.
Area of Science:
- Virology
- Infectious Diseases
- Drug Discovery
Background:
- Dengue virus (DENV) is a major global public health concern, affecting over half the world's population.
- Current treatment options are limited, with no specific antiviral therapies available and vaccine use restricted in certain age groups.
Purpose of the Study:
- To review anti-DENV small molecules and their targets published between 2014-2018.
- To discuss potential mechanisms of action for these agents.
- To explore the role of existing and novel drug classes in dengue therapy.
Main Methods:
- Literature review of scientific publications from 2014-2018.
- Analysis of small molecules targeting DENV.
- Identification and categorization of drug targets and mechanisms of action.
Main Results:
- Several small molecules targeting DENV have entered clinical trials.
- Identified various drug targets and elucidated probable mechanisms of action.
- Highlighted the potential of both approved and unclassified anti-DENV agents.
Conclusions:
- Small molecules represent a promising avenue for dengue antiviral therapy.
- Further research into novel agents and their targets is crucial for developing effective dengue treatments.
- Understanding drug mechanisms can accelerate innovation in dengue drug development.
Related Concept Videos
Drug Discovery: Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Waterproofing and Anti-Bacterial Admixtures in Concrete
Waterproofing admixtures render concrete hydrophobic,...
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids
Radical Anti-Markovnikov Addition to Alkenes: Overview

